An ascending single dose study of the safety and pharmacokinetics of IMA-638 administered to healthy Japanese subjects
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2014
At a glance
- Drugs Anrukinzumab (Primary)
- Indications Asthma; Ulcerative colitis
- Focus Adverse reactions
- 24 Jul 2007 Status changed from recruiting to completed.
- 08 Oct 2006 New trial record.